ERBB2 and breast cancer: Indeed, a number of sensitive Hsp90 clients have been implicated in the pathogenesis of breast cancer, including steroid hormone receptors (ER and PR), receptor tyrosine kinases (HER2, epidermal growth factor receptor (EGFR)) and intermediates of oncogenic signaling cascades (AKT and RAF1) [17].